AMHRII binding compounds for prevention or treatment of cancer

The present invention relates to the use of human AMHRII binding agents for the prevention or treatment of cancers selected from the cancer group comprising colon, liver, hepatocellular, testicular, thyroid, gastric, gastrointestinal, bladder, pancreatic, head and neck, kidney, liposarcoma, pleural mesothelioma, melanoma, sarcoma, brain, bone and leukemia. 本发明涉及人AMHRII结合剂用于预防或治疗选自包括以下的癌症组的癌症的用途：结肠癌、肝癌、肝细胞癌、睾丸癌、甲状腺癌、胃癌、胃肠癌、膀胱癌、胰腺癌、头颈癌、肾癌、脂肪肉瘤、胸膜间皮瘤、黑素瘤、肉瘤、脑癌、骨癌和白血病。